Welcome to ID Insights, the podcast that dives deep into the latest publications, trends, and advancements in the world of infectious diseases. Hosted by an experienced infectious diseases pharmacist and educator, this podcast offers expert analysis, key takeaways, and practical applications from cutting-edge research. Whether you’re a healthcare professional, researcher, or simply passionate about understanding infectious diseases, ID Insights provides valuable perspectives to keep you informed and inspired. Join us as we explore groundbreaking studies.
Infectious Diseases Insights
Claim This Podcastby Dr. Kayihura Manigaba, PharmD, BCIDP
1 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
Welcome to ID Insights, the podcast that dives deep into the latest publications, trends, and advancements in the world of infectious diseases. Hosted by an experienced infectious diseases pharmacist and educator, this podcast offers expert analysis, key takeaways, and practical applications from cutting-edge research. Whether you’re a healthcare professional, researcher, or simply passionate about understanding infectious diseases, ID Insights provides valuable perspectives to keep you informed and inspired. Join us as we explore groundbreaking studies.
Language
🇺🇲
Publishing Since
11/18/2024
Reach the team behind Infectious Diseases Insights
Verified contact details for this show aren't on file yet — sign up to get notified when they land.
Recent Episodes
November 18, 2024
Sulbactam-Durlobactam for CRAB Meningitis
<p>This study reports a case of a 42-year-old woman who successfully recovered from Carbapenem-Resistant Acinetobacter baumannii/calcoaceticus complex (CRAB) meningitis after being treated with sulbactam-durlobactam and meropenem. Despite initial treatment with high-dose ampicillin-sulbactam and cefiderocol, the patient’s CSF cultures remained positive for 13 days. After transitioning to the combination of sulbactam-durlobactam and meropenem, her infection cleared. The study also highlights a potential paradoxical effect of cefiderocol, where bacterial growth is observed at lower dilutions but not at higher dilutions. This effect is likely due to mutations in the TonB-dependent iron transport pathway, which can lead to cefiderocol resistance.</p> <p><br /></p> <p><strong>Reference</strong></p> <p>Tamma PD, Immel S, Karaba SM, et al. Successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis with sulbactam-durlobactam. Clinical Infectious Diseases. 2024;79(4):819-825.</p>
1 total episodes available
Deep-dive analytics for Infectious Diseases Insights
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Infectious Diseases Insights?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.